Topoisomerases in human leukemia

Adv Pharmacol. 1994:29B:33-50. doi: 10.1016/s1054-3589(08)61130-8.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Camptothecin / therapeutic use
  • DNA Topoisomerases, Type I / physiology
  • DNA Topoisomerases, Type II / physiology
  • Drug Resistance, Neoplasm
  • Hematopoietic System / physiopathology
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / enzymology
  • Topoisomerase I Inhibitors*
  • Topoisomerase II Inhibitors*

Substances

  • Antineoplastic Agents
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • DNA Topoisomerases, Type I
  • DNA Topoisomerases, Type II
  • Camptothecin